Bladder Neoplasms

Molecular Analysis Of Bladder Cancer

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Image-Guided Tumorboost of Bladder Cancer

Bladder Cancer Patient-Reported Outcomes

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer